Related Experiment Video
Updated: May 12, 2026

03:19
Point-of-Care Kidney and Genitourinary Ultrasound in Adults: Image Acquisition
Published on: June 21, 2024
Over- or underfill: not all nephrotic states are created equal
Pediatric Nephrology (Berlin, Germany)
|March 27, 2013
Summary
The "overfill" hypothesis suggests nephrotic syndrome causes sodium retention, leading to edema. New evidence links urinary plasmin to epithelial sodium channel (ENaC) activation, potentially explaining edema formation and offering new treatment targets.
Area of Science:
- Nephrology
- Pathophysiology
- Molecular Medicine
Background:
- The traditional "underfill" hypothesis for nephrotic syndrome edema posits urinary protein loss reduces oncotic pressure, causing fluid extravasation.
- Clinical observations challenge the "underfill" model, leading to the development of the "overfill" hypothesis, which suggests primary sodium retention.
Discussion:
- Proteinuria in nephrotic syndrome may contain proteinases like plasmin, activating the epithelial sodium channel (ENaC) in the collecting duct.
- This activation is proposed as a mechanism for primary sodium retention and subsequent edema.
- The study presents evidence of increased urinary plasmin and ENaC activation in children with nephrotic syndrome.
Key Insights:
- Urinary plasmin activation of ENaC offers a novel explanation for edema in nephrotic syndrome.
- This mechanism suggests potential therapeutic strategies targeting ENaC blockade, such as with amiloride.
- The persistence of the overfill versus underfill debate highlights the complexity of nephrotic syndrome pathophysiology.
Outlook:
- Further research is needed to fully elucidate the role of plasmin-ENaC signaling in nephrotic syndrome.
- Investigating why ENaC blockers are not empirically established treatments and understanding persistent underfilling signs is crucial.
- Resolving the overfill/underfill controversy will advance our understanding and treatment of nephrotic syndrome.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Nephrons
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma happens...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...

